ArticleBMJ open2020

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).

Paolina Salamone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.